Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling"
- PMID: 21606102
- DOI: 10.1001/archinternmed.2011.200
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling"
Comment on
-
A quantitative analysis of adverse events and "overwarning" in drug labeling.Arch Intern Med. 2011 May 23;171(10):944-6. doi: 10.1001/archinternmed.2011.182. Arch Intern Med. 2011. PMID: 21606101 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
